Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human , Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 15 and 264 of Human ITM2B|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 1% BSA, 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-31441 targets ITM2B in IF, IHC (P), and WB applications and shows reactivity with Human and mouse samples.
The PA5-31441 immunogen is recombinant fragment corresponding to a region within amino acids 15 and 264 of Human ITM2B.
Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
AI256040, Bricd2b, ABRI, BRI, BRICD2B, imBRI2, RP11-196P14.1, FBD, BRI2, Bri2, E25BMM, E3-16, D14Sel6, Bri, E25B
ABri/ADan amyloid peptide, BRICHOS domain containing 2B, immature BRI2, integral membrane protein 2B, transmembrane protein BRI, Integral membrane protein 2B (E25B protein), ABRI, BRI, BRI2, BRICD2B, E25B, E3-16, FBD